Understanding Gum Disease and Bone Loss
Gum disease destroys the supporting structures around your teeth—the bone and periodontal ligament that hold your teeth in place. Once bone is lost due to periodontal disease, simply cleaning your teeth cannot restore it. Traditional gum surgery removes infected tissue and smooths root surfaces, but it doesn't regenerate lost bone. For years, treatment aimed only at stopping disease progression, not restoring what was lost. PDGF therapy represents a breakthrough approach that actually encourages bone and tissue regrowth.
When gum disease progresses, it creates defects in the bone surrounding your tooth roots—sometimes deep pockets that trap bacteria and make disease worse. These defects are mechanically problematic and biologically challenging to treat. Your body's natural healing capacity is limited, often leaving significant bone loss after disease treatment. PDGF therapy works by enhancing your body's natural healing response, stimulating it to actually regenerate lost bone and tissue.
How PDGF Works to Regenerate Bone
Platelet-derived growth factor (PDGF) is a naturally occurring substance your body produces, especially during healing processes. Scientists discovered that applying extra PDGF to periodontally diseased sites dramatically enhances healing. The growth factor works by recruiting bone-building cells to the treatment area and stimulating them to multiply and differentiate into bone-forming cells. Essentially, PDGF tells your body to build bone, accelerating the regrowth process beyond what natural healing alone achieves.
The FDA-approved PDGF product combines the growth factor with a bone graft material (GEM 21S), creating a paste that your periodontist applies directly into the bone defect during surgery. The growth factor releases gradually over weeks, keeping biological signaling that promotes regrowth throughout the healing process. This sustained release keeps your body's bone-building machinery active longer than natural healing would maintain it, resulting in much more bone regrowth.
Clinical Results: What PDGF Achieves
Clinical trials show that PDGF therapy produces superior outcomes compared to traditional periodontal surgery alone. Patients receiving PDGF treatment show average bone fill of about 65 percent of the original defect volume—meaning roughly two-thirds of the lost bone regenerates. This translates to measurable clinical improvements: pocket depths reduce by 3 to 4 millimeters, and clinical attachment level (a measure of how tightly your gums attach to your teeth) improves by 2 to 4 millimeters. These gains persist long-term—studies tracking patients for 3 to 5 years show stable regenerated bone and maintained attachment levels.
The success of PDGF treatment depends on several factors. Defects deeper than 4 millimeters respond best. Deep, three-walled defects (where bone is lost on three sides of the root) show superior results compared to shallow defects.
Smoking much reduces outcomes—smokers show about 25 to 40 percent less bone regrowth than non-smokers. Your ability to maintain excellent plaque control after treatment determines long-term success. The treatment opens an opportunity for bone regrowth, but this opportunity depends on your commitment to preventing recurrent disease.
The Surgical Procedure and What to Expect
PDGF treatment involves periodontal surgery where your periodontist accesses the bone defect, thoroughly removes diseased tissue, carefully planes your root surface, and applies the PDGF-containing paste directly to the defect. A resorbable barrier membrane is often placed over the defect to maintain space and prevent epithelial tissue from growing into the bone-forming area. The surgical site is protected with a periodontal dressing for 2 weeks, allowing initial healing.
You can expect some postoperative discomfort, typically peaking at 3 to 5 days and resolving greatly by 2 to 3 weeks. Mild bleeding and oozing may continue for 24 hours. Your tissues will appear red and slightly swollen initially, which is normal healing swelling. You'll receive specific postoperative instructions regarding diet (soft foods for several weeks), oral hygiene (gentle care avoiding the surgical site), and possibly an antimicrobial rinse to reduce bacterial infection risk during healing. Most patients resume normal function within 4 to 6 weeks.
Long-Term Maintenance and Success
Following PDGF treatment, you require more intensive periodontal upkeep initially—typically every 2 to 4 weeks for the first 3 months, then transitioning to standard 3 to 6 month recall intervals based on your individual risk profile. During early upkeep visits, your clinician uses gentle instrumentation to avoid traumatizing healing tissues. By 3 months, tissues are sufficiently mature to tolerate standard cleaning and instrumentation.
The critical factor determining long-term success is your commitment to excellent home care and expert upkeep. PDGF provides the biological advantage to regenerate bone, but this regenerated bone is not immune to recurrent disease. If you allow plaque to build up and gum disease to return, the treated site can break down again. Conversely, if you maintain rigorous plaque control through daily brushing and flossing plus regular expert cleanings, the regenerated bone remains stable and functional for years.
Who Benefits Most from PDGF Therapy
Ideal candidates for PDGF treatment show: adequate remaining bone (you can't regenerate from nothing), ability to maintain excellent plaque control, stable systemic health without immunosuppressive conditions, and realistic expectations about treatment. Patients with deep infrabony defects (vertical bone loss at tooth roots) are best suited for treatment. The defect must exceed about 4 millimeters depth to justify the cost and surgical treatment. Patients with multiple similar defects benefit from treating them sequentially over several appointments.
Link Text discusses initial treatment to optimize your periodontal health before considering PDGF therapy. Your periodontist may recommend standard scaling and root planing first, allowing your body to respond with natural healing, then pursuing PDGF treatment if substantial defects persist despite excellent home care.Smoking status much impacts your candidacy. While not an absolute contraindication, smokers should understand they'll achieve 25 to 40 percent less bone regrowth than non-smokers, making the investment less valuable. Smoking cessation before treatment optimization improves outcomes greatly. Patients with other conditions affecting bone metabolism (diabetes, bisphosphonate use, radiation history) require individual assessment, though PDGF therapy isn't absolutely contraindicated.
Cost and Insurance Coverage
PDGF therapy (GEM 21S) is expensive—typically $2,000 to $3,000 per application. Most dental insurance covers some or all of this cost if periodontal disease is documented and standard therapy has failed. Coverage varies widely by plan and insurance company. Discuss potential costs and coverage with your periodontist's office before proceeding. Many offices work with insurance companies to verify coverage and help with payment options.
Link Text describes less expensive initial treatment approaches. Your periodontist may recommend starting with standard scaling and root planing or other regenerative approaches before investing in PDGF therapy. Every patient's situation is unique—always consult your dentist before making treatment decisions.Conclusion
PDGF therapy represents an evidence-based approach to actual bone regrowth in periodontal defects—not just stopping disease, but restoring lost supporting structures. Treatment requires careful patient selection, meticulous surgical technique, and long-term commitment to plaque control. Results are predictable in appropriate candidates: about 65 percent of bone volume regenerates, with sustained improvements in pocket depth and clinical attachment. Success depends on your postoperative commitment to excellent home care combined with regular expert upkeep to prevent recurrent disease.
> Key Takeaway: PDGF therapy offers genuine bone regeneration potential for appropriate candidates with deep periodontal defects, but its success depends entirely on your ability to maintain excellent plaque control afterward and prevent recurrent disease. Smoking cessation before treatment significantly improves outcomes for smokers.